3rd Party Biotechnology Industry News

Terremoto Biosciences has spelt out how the California biotech will [...]

After initiating a wind-down more than 18 months ago and [...]

Astellas is preparing to close its Seattle site for its [...]

Takeda has pulled back from a research collaboration with a [...]

An FDA review of records found that results have not [...]

Kailera is taking another step into the competitive obesity market [...]

Spyre Therapeutics’ monoclonal antibody hit the key goal in a [...]

The second time is not the charm for Replimune’s melanoma [...]

Oricell Therapeutics has now raised over $110 million in its [...]

When Fierce last caught up with GSK’s head of oncology [...]